Position in GILD
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$591,625
+$43,591 QoQ
Shares Held
4,245
-4.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Koss-Olinger Consulting, LLC holds $866,167 across 3 Drug Manufacturers - General names.
All Filings in GILD
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $591,625 | 4,245 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $548,034 | 4,465 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,016,537 | 18,167 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $2,014,175 | 18,167 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $2,107,772 | 18,811 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $3,533,060 | 38,249 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,638,193 | 31,467 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $2,272,088 | 33,116 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $395,550 | 5,400 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $1,765,612 | 21,795 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $626,723 | 8,363 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $225,429 | 2,925 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $242,687 | 2,925 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $261,499 | 3,046 | Shares | Sole | 2023-02-14 | |
| 2022-03-31 | $212,414 | 3,573 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $359,419 | 4,950 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $295,046 | 4,224 | Shares | Sole | 2021-11-09 | |
| No filing history on record for this holder in this stock. | ||||||